Indication

Lialda is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC) and for the maintenance of remission of UC.

Important Safety Information

  • You should not take Lialda if you are allergic to salicylates (including mesalamine, aspirin, or aspirin-containing products) or to any of the ingredients of Lialda.
  • Reports of problems with kidney function have been associated with mesalamine-containing products like Lialda. Tell your doctor if you have or have had problems with your kidneys. It is recommended that all patients have their kidney function checked before starting Lialda and periodically while on therapy.

Read more

Indication

Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC) and for the maintenance of remission of UC.

Important Safety Information

Do not take Lialda if you are allergic to:

  • salicylates, such as aspirin, or medications that contain aspirin
  • aminosalicylates
  • mesalamine or any other ingredients in Lialda

Tell your doctor if you:

  • have or have had kidney problems. Kidney problems have been reported with medications that contain mesalamine, such as Lialda. Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda.
Read more

Patient Savings and Support

Shire, the marketer of Lialda, remains committed to helping patients get the Shire medications their physicians have prescribed. We offer pharmacy savings and patient assistance programs for eligible patients that may help save money on Lialda prescriptions.

In this section you can find information on our Pharmacy Savings Card. You’ll also find savings information for people who don’t have prescription insurance or are having trouble affording their ulcerative colitis medications.

IMPORTANT SAFETY INFORMATIONISI

Do not take Lialda (mesalamine) if you are allergic to:

  • salicylates, such as aspirin, or medications that contain aspirin
  • aminosalicylates
  • mesalamine or any other ingredients in Lialda

Tell your doctor if you:

  • have or have had kidney problems. Kidney problems have been reported with medications that contain mesalamine, such as Lialda. Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda.
  • have symptoms including cramping, stomach ache, bloody diarrhea, fever, headache, and rash. Medications that contain mesalamine, such as Lialda, have been associated with a condition that may be hard to tell apart from a UC flare. Call your doctor right away if you have any of these symptoms. He or she may tell you to stop taking Lialda.
  • are allergic to sulfasalazine, as you may also be allergic to Lialda or medications that contain mesalamine.
  • have or have had heart-related allergic reactions, such as inflammation of the heart muscle (myocarditis) or the lining of the heart (pericarditis). These reactions have been seen in patients taking Lialda or medications that contain mesalamine. Your chance of having these types of reactions may increase when taking Lialda.
  • have or have had liver problems. Problems with liver function have been reported in patients who have or have had liver problems and were taking medications that contain mesalamine, such as Lialda.
  • have a stomach blockage. It may take longer for Lialda to start working.

The most common side effects reported in clinical studies of Lialda were:

  • ulcerative colitis
  • headache
  • passing gas
  • abnormal liver function test results
  • stomach ache

In clinical studies of Lialda, inflammation of the pancreas also occurred. If this happens to you, your doctor may tell you to stop taking Lialda.

Other side effects may occur.

Before starting Lialda, tell your doctor about all medications you are taking, including:

  • non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen. Taking these medications with Lialda may increase your chance of kidney problems.
  • azathioprine and 6-mercaptopurine. Taking these medications with Lialda may increase your chance of blood disorders.

Please see Full Prescribing Information for Lialda (mesalamine)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

 
#1 Prescribed mesalamine by gastroenterologists
You are about to leave the Lialda® (mesalamine) Web site.
This link will take you to a Web site maintained by a third party, who is responsible for its content and privacy policy. Shire provides this link as a service to you. Our privacy policy does not apply to the Web site you are about to visit. We encourage you to read the privacy policy of every Web site you visit. Click Cancel to return to Lialda.com or OK to continue.
The information contained in this section of the site is intended for US health care professionals only. Click OK if you are a health care professional.
E-mail this page or Web site to a friend or loved one by filling out the form below. All fields are required.
E-mail this page only

Please select one.

E-mail this site
*Your First Name
Please enter your first name.
*Recipient’s First Name
Please enter the recipient’s first name.
*Your E-mail Address
Please enter a valid e-mail address.
*Recipient’s E-mail Address
Please enter a valid recipient’s e-mail address.

Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. Please click here to review our privacy policy.

Your e-mail has been sent.
E–mail this list of questions for the doctor — to yourself, a friend or a loved one — by filling out the form below. Fields marked with an asterisk (*) are required.
*Your First Name
Please enter your first name.
*Recipient’s First Name
Please enter the recipient’s first name.
*Your E-mail Address
Please enter a valid e-mail address.
*Recipient’s E-mail Address
Please enter a valid recipient’s e-mail address.

Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. Please click here to review our privacy policy.

Your e-mail has been sent.